首页> 外文期刊>Biomedical materials >Frontiers in urethra regeneration: current state and future perspective
【24h】

Frontiers in urethra regeneration: current state and future perspective

机译:尿道再生中的边界:当前的国家和未来的观点

获取原文
获取原文并翻译 | 示例
           

摘要

Despite the positive achievements attained, the treatment of male urethral strictures and hypospadiases still remains a challenge, particularly in cases of severe urethral defects. Complications and the need for additional interventions in such cases are common. Also, shortage of autologous tissue for graft harvesting and significant morbidity in the location of harvesting present problems and often lead to staged treatment. Tissue engineering provides a promising alternative to the current sources of grafts for urethroplasty. Since the first experiments in urethral substitution with tissue engineered grafts, this topic in regenerative medicine has grown remarkably, as many different types of tissue-engineered grafts and approaches in graft design have been suggested and tested in vivo. However, there have been only a few clinical trials of tissue-engineered grafts in urethral substitution, involving hardly more than a hundred patients overall. This indicates that the topic is still in its inception, and the search for the best graft design is continuing. The current review focuses on the state of the art in urethral regeneration with tissue engineering technology. It gives a comprehensive overview of the components of the tissue-engineered graft and an overview of the steps in graft development. Different cell sources, types of scaffolds, assembling approaches, options for vascularization enhancement and preclinical models are considered.
机译:尽管达到了积极的成就,但雄性尿道狭窄的治疗仍然是一个挑战,特别是在严重尿道缺陷的情况下。在这种情况下并发症和对额外干预的需求是常见的。此外,对接枝收集的自体组织的短缺和收获存在的位置的显着发病率,并且通常导致分阶段治疗。组织工程提供了对尿道成形术的目前的移植源来源的有希望的替代品。自尿道替代与组织工程移植物中的第一个实验以来,在再生药中的这种话题显着增长,因为已经提出了许多不同类型的组织工程移植物和移植设计中的方法,并在体内测试。然而,在尿道替代物中只有少数组织工程移植物的临床试验,涉及整体患者几乎不比多。这表明该主题仍处于成立状态,并且对最佳接枝设计的搜索仍在继续。目前的审查重点是尿道再生与组织工程技术的最新技术。它全面概述了组织工程移植物的组成部分和移植型开发步骤的概述。考虑了不同的细胞来源,脚手架类型,组装方法,血管化增强和临床前模型的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号